Microlax solution for recto / cc microclysters for children from 0 to 3 years, 4 pcs 5ml shortened. 47.3mm tip

Description

Composition
Active substance:
1 ml of solution contains: Sodium citrate – 90 mg, 70% sodium lauryl sulfoacetate – 12.9 mg (corresponding to 9 mg of sodium lauryl sulfoacetate), sorbitol solution 70% – 893 mg (corresponding to 625 mg sorbitol) ;.
Excipients:
Sorbic acid – 1 mg Glycerol – 125 mg Purified water to 1 ml.
Description:
Colorless, opalescent, viscous liquid.
Product form:
Solution for rectal administration. 5 ml of a solution for rectal administration mikroklizme single use (a polyethylene tube with a tip and a breakable seal). 4 microclysters together with instructions for use in a cardboard package.
Contraindications
Increased individual sensitivity to the drug.
Indications
Constipation, including with encopresis, preparation for endoscopic (rectoscopy) and X-ray examination of the gastrointestinal tract.
Interaction with other drugs
There is a risk of colonic necrosis while oral / rectal sodium polystyrenesulfonate and sorbitol constituting the drug.
Overdose
Not described.
pharmachologic effect
Pharmacological group:
Laxative.
Pharmacological properties:
MIKROLAKS® – combined preparation has a laxative effect. The effect occurs within 5-15 minutes. The preparation includes sodium citrate (peptizing agent which displaces the bound water contained in the stool), sodium lauryl sulfoacetate (liquefied intestine contents) and sorbitol (increases laxative effect by stimulation of water flow into the intestine). Increasing the amount of water due to liquefaction and peptization promotes softening of stools and intestinal emptying easier.
Pregnancy and breast-feeding
There are no adequate and well-controlled studies in pregnant women have been conducted. Since this drug is probably absorbed into the systemic circulation to a minor extent, if it is applied in accordance with the recommendations during pregnancy or lactation is not expected of adverse effects to the fetus or infant.
Conditions of supply of pharmacies
Without recipe.
side effects
According spontaneous adverse event messages
Adverse reactions that occur during treatment with the drug, that have been identified during the post-registration application, were classified as follows: very frequent (> 10%), frequent (> 1%, 0.1% and 0.01%, but
Disorders of the gastrointestinal tract. Very rare: abdominal pain (including abdominal discomfort, abdominal pain and upper abdominal); anorectal discomfort, loose stools.
Violations by the immune system. Very rarely hypersensitivity reactions (e.g. urticaria).
special instructions
If symptoms persist, avoid prolonged use and consult a doctor. If the drug has come into disrepair or expiration date – do not pour it into the waste water and not be thrown into the street! Place the drug in the bag and place in the trash. These measures will help protect the environment!
Effects on ability to drive vehicles and management mechanisms:
MIKROLAKS® does not affect the ability to drive vehicles and management mechanisms.
Storage conditions
At temperatures above 25 C of the reach of children.
Dosing and Administration
Infants and children up to 3 years. Audio content microclysters administered rectally inserting truncated tip the full length
If complaints persist for a long time to see a doctor.
Directions for use:
Break the tip seal on the tube.
Gently press down on the tube so as to drop the drug lubricated enema tip – it will facilitate the introduction process.
Squeezing the tube, squeeze out the contents completely. Remove the cap, still slightly squeezing the tube.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist